Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,396 | 239 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $864.74 | 41 | $0 (2024) |
| Novo Nordisk Inc | $464.47 | 43 | $0 (2022) |
| Amarin Pharma Inc. | $460.16 | 49 | $0 (2023) |
| PFIZER INC. | $247.09 | 19 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $158.50 | 11 | $0 (2023) |
| Amgen Inc. | $110.48 | 6 | $0 (2024) |
| Abbott Laboratories | $96.27 | 7 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $95.84 | 7 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $82.89 | 5 | $0 (2024) |
| ABBVIE INC. | $81.28 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $398.59 | 18 | AstraZeneca Pharmaceuticals LP ($150.99) |
| 2023 | $434.41 | 25 | AstraZeneca Pharmaceuticals LP ($177.97) |
| 2022 | $385.42 | 20 | AstraZeneca Pharmaceuticals LP ($153.39) |
| 2021 | $877.92 | 67 | AstraZeneca Pharmaceuticals LP ($232.02) |
| 2020 | $588.08 | 56 | Amarin Pharma Inc. ($186.72) |
| 2019 | $311.01 | 26 | Novo Nordisk Inc ($127.95) |
| 2018 | $218.90 | 13 | Amgen Inc. ($76.70) |
| 2017 | $181.22 | 14 | Takeda Pharmaceuticals America, Inc. ($38.79) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Cardiology | ||||||
| 10/03/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $19.43 | General |
| Category: Insulin Pump | ||||||
| 09/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: UROLOGY | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $29.16 | General |
| 09/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Inflammation | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Respiratory | ||||||
| 06/13/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.06 | General |
| 06/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.77 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Hematology | ||||||
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Respiratory | ||||||
| 03/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Diabetes Care | ||||||
| 03/06/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Hematology | ||||||
| 02/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), FARXIGA, BREZTRI | Food and Beverage | In-kind items and services | $90.31 | General |
| Category: Respiratory | ||||||
| 12/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/08/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.16 | General |
| 10/11/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: RESPIRATORY | ||||||
| 08/18/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Hematology | ||||||
| 08/14/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,083 | 2,083 | $307,569 | $164,359 |
| 2022 | 18 | 1,432 | 2,590 | $338,842 | $184,428 |
| 2021 | 14 | 1,160 | 2,271 | $315,597 | $171,953 |
| 2020 | 17 | 1,739 | 3,246 | $422,934 | $201,037 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 270 | 713 | $111,228 | $57,874 | 52.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 282 | 699 | $90,414 | $39,565 | 43.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 244 | 244 | $40,504 | $29,891 | 73.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 49 | 59 | $13,806 | $8,811 | 63.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 62 | 142 | $15,140 | $8,692 | 57.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 60 | $8,723 | $5,605 | 64.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 38 | $11,175 | $5,173 | 46.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 61 | 76 | $8,119 | $4,628 | 57.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 40 | $8,160 | $4,021 | 49.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 12 | $300.00 | $99.65 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 299 | 770 | $120,120 | $59,210 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 298 | 745 | $78,970 | $41,319 | 52.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 260 | 260 | $43,160 | $32,316 | 74.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 110 | 283 | $28,464 | $15,414 | 54.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 51 | 54 | $16,254 | $8,208 | 50.5% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 42 | 49 | $11,466 | $7,365 | 64.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 41 | 64 | $9,519 | $5,049 | 53.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 71 | 91 | $9,750 | $4,961 | 50.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 32 | 37 | $7,548 | $3,830 | 50.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 89 | 89 | $2,314 | $1,488 | 64.3% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $2,436 | $1,236 | 50.7% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2022 | 12 | 15 | $1,620 | $833.51 | 51.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 47 | 47 | $1,222 | $768.51 | 62.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 21 | $1,153 | $636.61 | 55.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 12 | 12 | $1,218 | $628.65 | 51.6% |
About Dr. Radhakrishna Kukkillaya, M.D
Dr. Radhakrishna Kukkillaya, M.D is a Internal Medicine healthcare provider based in Logan, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114981156.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Radhakrishna Kukkillaya, M.D has received a total of $3,396 in payments from pharmaceutical and medical device companies, with $398.59 received in 2024. These payments were reported across 239 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,396).
As a Medicare-enrolled provider, Kukkillaya has provided services to 5,414 Medicare beneficiaries, totaling 10,190 services with total Medicare billing of $721,777. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Logan, WV
- Active Since 04/14/2006
- Last Updated 01/24/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1114981156
Products in Payments
- FARXIGA (Drug) $633.57
- Vascepa (Drug) $460.16
- Ozempic (Drug) $330.76
- ELIQUIS (Drug) $201.78
- AIRSUPRA (Drug) $135.35
- XIFAXAN (Drug) $132.80
- GEMTESA (Drug) $98.38
- Prolia (Biological) $92.48
- BREZTRI (Drug) $55.40
- ENTRESTO (Drug) $55.35
- XARELTO (Drug) $51.07
- ACCRUFER (Drug) $50.95
- FreeStyle Libre 2 (Device) $50.86
- NEXLETOL (Drug) $46.87
- RYBELSUS (Drug) $45.83
- FREESTYLE LIBRE 2 (Device) $45.41
- CHANTIX (Drug) $44.47
- SOLIQUA 100/33 (Biological) $38.49
- INJECTAFER (Drug) $36.00
- UBRELVY (Drug) $33.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Logan
Dr. Waris Waris
Internal Medicine — Payments: $11,096
Steven Salisbury, Md, MD
Internal Medicine — Payments: $9,965
Dr. Kozhaya Mallah, Md, MD
Internal Medicine — Payments: $8,931
Dr. Jonathan Rhee, M.d, M.D
Internal Medicine — Payments: $7,036
Haytham Alkhaimy
Internal Medicine — Payments: $6,170
Dr. John Ireton, D.o, D.O
Internal Medicine — Payments: $1,675